THURSDAY, JANUARY 16
9:00 am | Session 1: Early Embryonic Development: An Up-to-Date Account. John M. Opitz, M.D., Professor of Pediatrics, Human Genetics, and Obstetrics/Gynecology, School of Medicine, University of Utah. |
10:30 am | Break |
10:45 am | Session 2: Procuring Organs for Transplantation: Ethical Considerations. Council Discussion. |
12:15 pm | Lunch |
2:00 pm | Session 3: Beyond Therapy: Biotechnology and the Pursuit of Human Improvement: Discussion of a Paper Prepared by Leon R. Kass, M.D. |
3:30 pm | Break |
3:45 pm | Session 4: Beyond Therapy: Controlling Sex of Children. Discussion of Staff Working Paper, "Ethical Aspects of Sex Control" |
5:15 pm | Adjournment |
8:30 am | Session 5: Biotechnology and Public Policy: Role of the Food and Drug Administration (FDA). Richard A. Merrill, M.A., LL.B., Daniel Caplin Professor of Law and Sullivan & Cromwell Research Professor, University of Virginia School of Law, and Of Counsel, Covington & Burling, Washington, D.C. James S. Benson, former Acting Commissioner, U.S. Food and Drug Administration. |
10:30 am | Break |
10:45 am | Session 6: Neuropsychopharmacology and Public Policy. Council Discussion. |
11:30 pm | Public Comments. |
12:30 pm | Adjournment |